The DOI matches its Crossref record.
Dermoscopic Evaluation of Amelanotic and Hypomelanotic Melanoma
Open accessAbstract
OBJECTIVE: To determine the predictive dermoscopic features of amelanotic and hypomelanotic melanoma. DESIGN: A total of 105 melanomas (median Breslow thickness, 0.76 mm), 170 benign melanocytic lesions, and 222 nonmelanocytic lesions lacking significant pigment (amelanotic, partially pigmented, and light colored) were imaged using glass-plate dermoscopy devices and scored for 99 dermoscopic features. Diagnostic models were derived from and tested on independent randomly selected lesions. SETTING: Predominantly hospital-based clinics from 5 continents. MAIN OUTCOME MEASURES: Sensitivity, specificity, and odds ratios for individual features and models for the diagnosis of melanoma and malignancy. RESULTS: The most significant negative predictors of melanoma were having multiple (>3) milialike cysts (odds ratio, 0.09; 95% confidence interval, 0.01-0.64), comma vessels with a regular distribution (0.10; 0.01-0.70), comma vessels as the predominant vessel type (0.16; 0.05-0.52), symmetrical pigmentation pattern (0.18; 0.09-0.39), irregular blue-gray globules (0.20; 0.05-0.87), and multiple blue-gray globules (0.28; 0.10-0.81). The most significant positive predictors were having a blue-white veil (odds ratio,13; 95% confidence interval, 3.9-40.0), scarlike depigmentation (4.4; 2.4-8.0), multiple blue-gray dots (3.5; 1.9-6.4), irregularly shaped depigmentation (3.3; 2.0-5.3), irregular brown dots/globules (3.2; 1.8-5.6), 5 to 6 colors (3.2; 1.6-6.3), and predominant central vessels (3.1; 1.6-6.0). A simple model distinguishing melanomas from all nonmelanomas had a sensitivity of 70% and a specificity of 56% in the test set. A model distinguishing all malignant lesions from benign lesions had a sensitivity of 96% and a specificity of 37%. Conclusion Although the diagnostic accuracy of dermoscopy for melanoma lacking significant pigment is inferior to that of more pigmented lesions, features distinguishing the former from benign lesions can be visualized on dermoscopic evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
How to diagnose nonpigmented skin tumors: A review of vascular structures seen with dermoscopy
Zalaudek, I., Kreusch, J., Giacomel, J., Ferrara, G., Catricalà, C., & Argenziano, G. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.11.697 · Cited by 346
Self-citationVascularización en dermatoscopia
Martín, J. M., Bella-Navarro, R., & Jordá, E. (2012) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2011.11.005 · Cited by 81
Chen, J. Y., Fernandez, K., Fadadu, R. P., Reddy, R., Kim, M.-O., Tan, J., & Wei, M. L. (2025) · JAMA Dermatology · doi:10.1001/jamadermatol.2024.4382 · Cited by 43
Artificial intelligence for melanoma diagnosis: how can we deliver on the promise?
Mar, V. J., & Soyer, H. P. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy193 · Cited by 37
Self-citationStricklin, S. M., Stoecker, W. V., Oliviero, M. C., Rabinovitz, H. S., & Mahajan, S. K. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03920.x · Cited by 33
Self-citationSurvival Is Not the Only Valuable End Point in Melanoma Screening
Curiel-Lewandrowski, C., Kim, C. C., Swetter, S. M., Chen, S. C., Halpern, A. C., Kirkwood, J. M., Leachman, S. A., Marghoob, A. A., Ming, M. E., & Grichnik, J. M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.3 · Cited by 26
Self-citation
Metadata
- Authors
- Menzies, S. W., Kreusch, J., Byth, K., Pizzichetta, M. A., Marghoob, A., Braun, R., Malvehy, J., Puig, S., Argenziano, G., Zalaudek, I., Rabinovitz, H. S., Oliviero, M., Cabo, H., Ahlgrimm-Siess, V., Avramidis, M., Guitera, P., Soyer, H. P., Ghigliotti, G., Tanaka, M., Perusquia, A. M., Pagnanelli, G., Bono, R., Thomas, L., Pellacani, G., Langford, D., Piccolo, D., Terstappen, K., Stanganelli, I., Llambrich, A., & Johr, R.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2008-09-01
- Volume
- 144
- Issue
- 9
- Pages
- 1120-7
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2026308024
- Cited by
- 306
- References
- 0
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.